PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE
SIREN : 817650898
Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2016-01-15 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VITRY-SUR-SEINE (94400), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE : revenue, balance sheet and financial ratios
PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VITRY-SUR-SEINE (94400),
this company of category PME
shows in 2016 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE (SIREN 817650898)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 386 431 €
Net income
163 578 €
224 127 €
354 422 €
326 195 €
207 053 €
198 076 €
185 583 €
139 473 €
67 567 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
104 172 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
4.9%
Revenue and income statement
In 2024, PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE generates positive net income of 164 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 68 k€ -> 164 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
163 578 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 9%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 85%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
8.816%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
85.146%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
763.241
326.825
165.372
116.051
71.126
47.451
29.752
16.908
8.816
Financial autonomy
10.047
20.75
33.757
40.937
52.337
53.42
67.301
77.046
85.146
Repayment capacity
12.824
None
None
None
None
None
None
None
None
Cash flow / Revenue
5.047%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
8.822024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE DU THEATRE SELA... (8.82) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
85.15%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+11 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU THEATRE SELA... (85.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 690.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
690.337
Liquidity indicators evolution PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
192.616
259.659
278.948
283.112
366.152
231.588
365.328
490.057
690.337
Interest coverage
11.726
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
690.342024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of PHARMACIE DU THEATRE SELA... (690.34) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
14 516 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
19
0
0
0
0
0
0
0
0
Customer payment term (days)
3
0
0
0
0
0
0
0
0
Supplier payment term (days)
22
0
0
0
0
0
0
0
0
Positioning of PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE is estimated at
2 283 669 €
(range 1 590 311€ - 3 416 500€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1590k€2283k€3416k€
2 283 669 €Range: 1 590 311€ - 3 416 500€
NAF 5 année 2024
Valuation method used
Net Income Multiple
163 578 €
×
14.0x
=2 283 670 €
Range: 1 590 312€ - 3 416 501€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE
What is the revenue of PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE ?
The revenue of PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE in 2016 is 1.4 M€.
Is PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE profitable?
Yes, PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE generated a net profit of 164 k€ in 2024.
Where is the headquarters of PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE ?
The headquarters of PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE is located in VITRY-SUR-SEINE (94400), in the department Val-de-Marne.
Where to find the tax return of PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE ?
The tax return of PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE operate?
PHARMACIE DU THEATRE SELARL DE PHARMACIENS D'OFFICINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart